BiopharmaLynx

BiopharmaLynx™ automates the processing and interpretation of biopharmaceutical product LC/MS data, enabling you to characterize your products. Developed with biopharmaceutical thought leaders for confident characterization and optimized workflow, BiopharmaLynx™ leverages Waters' leading protein informatics expertise. Determine the identity, purity and stability of biopharmaceuticals, working with either peptide maps or intact proteins.BiopharmaLynx Features: Automatically process your accurate mass MS data, including peptide map results and intact mass measurements. Automatically analyze and assign results, define the sequence and features of known proteins and determine the identity of modified forms. Allow your users to edit assignments, annotate new peaks and compare experiment...Read more

Receive your quote directly from Waters.

Reviews

0 Scientists have reviewed this product


Write the First Review

No Reviews

Description

BiopharmaLynx™ automates the processing and interpretation of biopharmaceutical product LC/MS data, enabling you to characterize your products.

Developed with biopharmaceutical thought leaders for confident characterization and optimized workflow, BiopharmaLynx™ leverages Waters' leading protein informatics expertise. Determine the identity, purity and stability of biopharmaceuticals, working with either peptide maps or intact proteins.


BiopharmaLynx Features:

  • Automatically process your accurate mass MS data, including peptide map results and intact mass measurements.
  • Automatically analyze and assign results, define the sequence and features of known proteins and determine the identity of modified forms.
  • Allow your users to edit assignments, annotate new peaks and compare experimental samples with a reference using visualization and tabular tools.
  • Automatically generate biopharmaceutical-specific reports from templates.
  • Identify and quantify ions in a peptide map, including intra- and inter-sample relative quantitation.
  • Assign ions to expected and modified peptides from a defined protein sequence, determining sequence coverage and ID-modified peptides.
  • Define deconvolution settings for known proteins and as generic for unknown proteins.
  • Annotate deconvoluted mass data with protein identities and their modifications.
  • Automatically calculate percentages of each protein variant.

Product Overview







Receive your quote directly from Waters for BiopharmaLynx